These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7498987

  • 21. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats.
    Widdop RE, Sampey DB, Jarrott B.
    Hypertension; 1999 Oct; 34(4 Pt 2):964-8. PubMed ID: 10523392
    [Abstract] [Full Text] [Related]

  • 22. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B, de Vries R, Saxena PR, Danser AH.
    Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats.
    Wood JM, Mah SC, Schnell C.
    J Cardiovasc Pharmacol; 1990 Jul; 16 Suppl 4():S60-4. PubMed ID: 1705630
    [Abstract] [Full Text] [Related]

  • 24. Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions.
    Poh TF, Ng HK, Hoe SZ, Lam SK.
    J Cardiovasc Pharmacol; 2013 May; 61(5):378-84. PubMed ID: 23328388
    [Abstract] [Full Text] [Related]

  • 25. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF, Pessa LR, Tanus-Santos JE.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):173-7. PubMed ID: 19233159
    [Abstract] [Full Text] [Related]

  • 26. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
    Lindsey CJ, Bendhack LM, Paiva AC.
    J Hypertens Suppl; 1987 Jul 01; 5(2):S71-6. PubMed ID: 2821209
    [Abstract] [Full Text] [Related]

  • 27. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X, Wagner C, Chatziantoniou C, Kurtz A, Arendshorst WJ.
    J Clin Invest; 1997 Mar 01; 99(5):1072-81. PubMed ID: 9062366
    [Abstract] [Full Text] [Related]

  • 28. Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs.
    Wamberg C, Plovsing RR, Sandgaard NC, Bie P.
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov 01; 285(5):R971-80. PubMed ID: 12869367
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Potentiation of depressor responses to arachidonic acid by angiotensin converting enzyme inhibitors in the rat.
    Hui SC, Dai S, Ogle CW.
    Clin Exp Pharmacol Physiol; 1984 Nov 01; 11(6):621-5. PubMed ID: 6100239
    [Abstract] [Full Text] [Related]

  • 31. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
    Neto-Neves EM, Montenegro MF, Dias-Junior CA, Spiller F, Kanashiro A, Tanus-Santos JE.
    Basic Clin Pharmacol Toxicol; 2010 Oct 01; 107(4):825-9. PubMed ID: 20406213
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed.
    Lindsey CJ, Bendhack LM, Paiva AC.
    J Pharmacol Exp Ther; 1987 Oct 01; 243(1):292-6. PubMed ID: 2822902
    [Abstract] [Full Text] [Related]

  • 34. The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat.
    Weaver-Osterholtz D, Reams G, De Vergel CF, Bauer JH.
    J Urol; 2001 May 01; 165(5):1735-8. PubMed ID: 11342966
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M, Schiavi P, Vincent M, Schmitt H.
    J Cardiovasc Pharmacol; 1984 May 01; 6(6):1076-82. PubMed ID: 6084763
    [Abstract] [Full Text] [Related]

  • 36. Comparison of blood pressure responses to intra-arterial and intra-venous injections of angiotensin I, angiotensin II and bradykinin.
    Heller LJ, Mohrman DE.
    Life Sci; 1998 May 01; 62(9):PL121-5. PubMed ID: 9496705
    [Abstract] [Full Text] [Related]

  • 37. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment.
    Mullane KM, Moncada S.
    Eur J Pharmacol; 1980 Sep 05; 66(4):355-65. PubMed ID: 6998710
    [Abstract] [Full Text] [Related]

  • 38. Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
    Trippodo NC, Panchal BC, Fox M.
    J Pharmacol Exp Ther; 1995 Feb 05; 272(2):619-27. PubMed ID: 7853175
    [Abstract] [Full Text] [Related]

  • 39. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
    Hayashi MA, Murbach AF, Ianzer D, Portaro FC, Prezoto BC, Fernandes BL, Silveira PF, Silva CA, Pires RS, Britto LR, Dive V, Camargo AC.
    J Neurochem; 2003 May 05; 85(4):969-77. PubMed ID: 12716428
    [Abstract] [Full Text] [Related]

  • 40. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW, Kwiecien S, Ptak-Belowska A, Pajdo R, Olszanecki R, Suski M, Madej J, Targosz A, Konturek SJ, Korbut R, Brzozowski T.
    J Physiol Pharmacol; 2016 Feb 05; 67(1):75-91. PubMed ID: 27010897
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.